By Timothy s. Donahue

Top Takeaways:

• FDA action: The agency issued warning letters to eight retailers that were selling unauthorized nicotine pouches and dissolvable tobacco products.
• Youth concerns: Regulators said some products were designed to look like candy, cough drops and breath strips.
• Enforcement grows: The action follows the FDA’s recent enforcement guidance targeting unauthorized nicotine pouches and ENDS products.

The U.S. Food and Drug Administration is intensifying enforcement against nicotine products that resemble everyday consumer items.

The FDA announced it issued warning letters to eight retailers for selling unauthorized tobacco products, including nicotine pouches and dissolvable tobacco products, that regulators say mimic candy, breath strips and cough drops through their labeling, advertising or overall design.

The agency said the products raise two major concerns: accidental ingestion by young children and the ability of youth users to conceal nicotine products from parents, teachers, and other adults.

“No tobacco product should look like candy—it’s a blatant ploy to target children and mask the true nature of these products,” said Bret Koplow, acting director of FDA’s Center for Tobacco Products. “FDA and its partners are committed to implementing an aggressive enforcement strategy to stop illegal products like these from ending up on shelves or in the hands of kids.”

According to the FDA, the products cited in the warning letters lack the required premarket authorization and therefore cannot legally be marketed or sold in the United States under the Federal Food, Drug, and Cosmetic Act.

The agency said retailers were instructed not only to address the specific violations identified in the letters but also to correct any “same or similar” violations involving comparable products. The FDA warned that failure to comply could result in additional enforcement actions, including injunctions, product seizures, and civil money penalties.

The action comes shortly after the FDA released updated enforcement guidance outlining priorities for unauthorized electronic nicotine delivery systems (ENDS) and nicotine pouch products.

The agency said unauthorized nicotine products undermine the federal tobacco regulatory system because they have not undergone FDA scientific review of toxicological risk, ingredient composition and population-level public health impact.

FDA has sharply increased enforcement activity related to unauthorized nicotine products over the past several years, particularly targeting flavored disposable vapes and newer oral nicotine formats.

According to the agency, the FDA has now issued more than 800 warning letters to manufacturers, distributors, and sellers tied to unauthorized new tobacco products, and more than 1,000 warning letters to retailers for unauthorized tobacco sales.